- Jan 8, 2016

MSU prof breaks ground with childhood cancer discovery

Today the drug is in clinical trials in 24 U.S. hospitals. Patient trials are aimed at assessing the drug's effectiveness against neuroblastoma. If successful, it could help raise the survival rate for children battling an often unforgiving disease.

Intensive Treatment May Pose Fertility Risks in Childhood Cancer Survivors

They survived childhood cancer. But the disease has taken a toll on their mental health.

How you can support a parent who has a child with cancer

Developing ‘kinder’ treatments for a devastating childhood cancer

Breakthrough as new drug promises to shield child cancer patients from hearing loss

Study finds higher breast cancer risk after certain forms of childhood cancer treatment

Aggressive Cancer Cells Transformed Into Healthy Cells in Breakthrough

Cardiac RT May Amplify Late Disease Risk in Pediatric Cancer Survivors

Are Cannabis-Based Medicines Safe for Children With Cancer?

Homoharringtonine May be ‘Better Alternative’ to Etoposide In Pediatric AML

Recent Posts

MSU prof breaks ground with childhood cancer discovery

Archive

Search By Tags